NCT06279650 Self-hypnosis Training for Chronic Pain Management
| NCT ID | NCT06279650 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ciusss de L'Est de l'Île de Montréal |
| Condition | Hypnosis, Chronic Pain Management |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2025-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-02-01 with a primary completion date of 2025-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Title: Self-hypnosis training in chronic pain management: A pilot study Our primary objective concerns the effect of hypnosis intervention on change in 24h pain between T0 (pre-intervention) and T4 (3-month follow-up). The secondary objectives concern the effects of the intervention on (i) change in 24h pain between T0 and T5 (6-month follow-up), (ii) changes from T0 in measures of the functional impact of pain, (iii) changes from T0 in anxiety-depression scores and (iv) changes from T0 in quality of life. The study design is a Randomized efficacy pilot study. The study focuses on patients practicing self-hypnosis within HMR groups. The study population is pain clinic patients. The sample size is 60 pain clinic patients. Study duration: February 2024 - December 2024. Center responsible for the study: Centre de Recherche de l'Hôpital Maisonneuve-Rosemont (CR-HMR) - CEMTL, Montreal, Quebec, Canada. Adverse events: none expected.
Eligibility Criteria
Inclusion Criteria: * Inclusion criteria were to have participated in the past year in the self-hypnosis training program and to agree to take part in these research interviews. * be 18 years of age or older; * have received one of the above diagnoses, confirmed by medical record review or physician confirmation; * report pain that has been present for at least 3 months; * have a pain intensity over the last 24 hours (24h pain) of at least 4 on a Numerical Rating Scale (NRS) from 0 to 10 at baseline; * be able to read, speak and understand French; * have Internet access and be able to participate in a telepractice intervention group and complete online questionnaires. Exclusion Criteria: * have deafness and/or severe cognitive impairment that may impair communication; * have current or recent psychiatric instability (e.g., active suicidal ideation, active delusional or psychotic thoughts) that could interfere with participation, as assessed by a clinical psychologist.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06279650 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hypnosis, Chronic Pain Management. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06279650 currently recruiting?
Yes, NCT06279650 is actively recruiting participants. Contact the research team at david.ogez@umontreal.ca for enrollment information.
Where is the NCT06279650 trial being conducted?
This trial is being conducted at Montreal, Canada.
Who is sponsoring the NCT06279650 clinical trial?
NCT06279650 is sponsored by Ciusss de L'Est de l'Île de Montréal. The trial plans to enroll 60 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.